替吉奥联合吉非替尼治疗EGFR-TKI获得性耐药晚期NSCLC的临床疗效
沈静侠, 韩彬, 王淑颖, 康海立, 王立东, 刘旭辉, 崔庆贵
Clinical efficacy of S-1 combined with gefitinib in the treatment of advanced NSCLC with EGFR-TKI acquired drug resistance
Shen Jingxia, Han Bin, Wang Shuying, Kang Haili, Wang Lidong, Liu Xuhui, Cui Qinggui
国际肿瘤学杂志
.
2019, (12): 723
-727
.
DOI: 10.3760/cma.j.issn.1673-422X.2019.12.004
